文献速递生殖医学

精液采集地点对精液参数和生育结局的影响及其在COVID-19时代的实践意义:随机与观察性研究的系统综述和Meta分析

Effect of semen collection location on semen parameters and fertility outcomes and implications for practice in the COVID-19 era: a systematic review and meta-analysis of randomized and observational studies.
PubMed 文献 · Am J Obstet Gynecol · 2022-09-13

该系统综述与Meta分析纳入7项研究(3018份精液样本),比较家庭与诊所精液采集对精液参数及辅助生殖结局的影响。家庭采集在精液量、精子计数、精子活力、受精率和体外受精妊娠率方面与诊所采集无显著差异,但证据质量低至极低,需更高质量证据。

要点

  • 家庭与诊所精液采集在精液量、精子计数和精子活力上差异无统计学意义。
  • 家庭与诊所采集的受精率(RR 1.00)和体外受精妊娠率(RR 1.04)无差异。
  • 证据质量低至极低,作者认为需要更高质量证据。

核心结论

  • 与诊所精液采集相比,家庭精液采集对精液参数或生育结局无不良影响,但需要更高质量的证据。

研究设计与样本

  • 系统综述与Meta分析,纳入所有比较家庭与诊所精液采集对精液参数和生育结局影响的人类随机对照试验和观察性研究,共7项研究(3018份精液样本)。
  • 检索MEDLINE via Ovid、EMBASE、Scopus、CINAHL、OpenGrey和CENTRAL从建库至2021年9月,并检索ClinicalTrials.gov识别正在注册的临床试验。
  • 使用Review Manager 5.4.1版(The Cochrane Collaboration,2022)合并均数差和风险比,并采用GRADE方法评估证据质量。

主要发现

  • 家庭精液采集与诊所采集相比,精液量均数差0.37(95%CI -0.10至0.85;低质量证据),差异很小至无差异。
  • 精子计数均数差-6.02(95%CI -27.26至15.22;极低质量证据),差异无统计学意义。
  • 精子活力均数差0.76(95%CI -4.39至5.92;极低质量证据),差异无统计学意义。
  • 受精率风险比1.00(95%CI 0.97-1.03;极低质量证据),无差异。
  • 体外受精妊娠率风险比1.04(95%CI 0.86-1.25;极低质量证据),无差异。

关键数值与推荐

  • 精液量均数差0.37(95%CI -0.10至0.85;低质量证据)。
  • 精子计数均数差-6.02(95%CI -27.26至15.22;极低质量证据)。
  • 精子活力均数差0.76(95%CI -4.39至5.92;极低质量证据)。
  • 受精率风险比1.00(95%CI 0.97-1.03;极低质量证据)。
  • 体外受精妊娠率风险比1.04(95%CI 0.86-1.25;极低质量证据)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 精液量证据质量为低质量。
  • 精子计数、精子活力、受精率和体外受精妊娠率的证据质量均为极低质量。
  • 作者结论指出需要更高质量的证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: During the COVID-19 era, semen collection at infertility centers might increase the risk of spreading SARS-CoV-2. Seminal fluid collection at home is an alternative method for preventing this spread. However, there is no conclusion about the effect of home vs clinic semen collection on semen parameters and assisted reproductive technology outcomes. This systematic review and metaanalysis aimed to assess the effect of semen collection location on semen parameters and fertility outcomes. DATA SOURCES: A literature search was conducted using the major electronic databases including MEDLINE via Ovid, EMBASE, Scopus, CINAHL, OpenGrey, and CENTRAL from their inception to September 2021. CLINICALTRIALS: gov was searched to identify the ongoing registered clinical trials. STUDY ELIGIBILITY CRITERIA: We included all human randomized controlled trials and observational studies that investigated the effect of at-home semen collection vs in-clinic semen collection on semen parameters and fertility outcomes. METHODS: We pooled the mean difference and risk ratio using Review Manager software version 5.4.1 (The Cochrane Collaboration, 2022). The Grading of Recommendations, Assessment, Development and Evaluations approach was applied to assess the quality of evidence. RESULTS: Seven studies (3018 semen samples) were included. Overall, at-home semen collection results made little to no difference in semen volume (mean difference, 0.37; 95% confidence interval, -0.10 to 0.85; low-quality evidence), sperm count (mean difference, -6.02; 95% confidence interval, -27.26 to 15.22; very low-quality evidence), and sperm motility (mean difference, 0.76; 95% confidence interval, -4.39 to 5.92; very low-quality evidence) compared with in-clinic semen collection. There was no difference in fertilization rate (risk ratio, 1.00; 95% confidence interval, 0.97-1.03; very low-quality evidence) and pregnancy rate in in vitro fertilization (risk ratio, 1.04; 95% confidence interval, 0.86-1.25; very low-quality evidence). CONCLUSION: At-home semen collection had no adverse effects on semen parameters or fertility outcomes compared with in-clinic collection. However, higher-quality evidence is needed.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kerdtawee P, Salang L, Sothornwit J, et al. Effect of semen collection location on semen parameters and fertility outcomes and implications for practice in the COVID-19 era: a systematic review and meta-analysis of randomized and observational studies. Am J Obstet Gynecol. 2022. PMID: 36108728. doi:10.1016/j.ajog.2022.09.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。